The 'superbug' methicillin-resistant staphylococcus aureus, or MRSA, is a top concern for hospitals and doctors nationwide. So what are we doing to combat this? Dr. Gian Han, director of Diatherix Laboratories, tells host Bruce Japsen about molecular diagnostic technologies being developed for doctors to detect MRSA and prevent infection in patients.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
New Diagnostics to Combat MRSA 'Superbug'
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Presenters
Recommended
Details
Presenters
Comments
Recommended
Overview
The 'superbug' methicillin-resistant staphylococcus aureus, or MRSA, is a top concern for hospitals and doctors nationwide. So what are we doing to combat this? Dr. Gian Han, director of Diatherix Laboratories, tells host Bruce Japsen about molecular diagnostic technologies being developed for doctors to detect MRSA and prevent infection in patients.
Presenters
Facebook Comments